Skip to main content

Table 1 Patient characteristics

From: Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis

 

DMT-treated patients N = 14,627

Age (mean, SD), y

47.4

11.0

Age categories (n, %)

 18–24 y

341

2.3

 25–34 y

1488

10.2

 35–44 y

3885

26.6

 45–54 y

4958

33.9

 55–64 y

3161

21.6

 65–74 y

712

4.9

 75–84 y

77

0.5

 85+ y

5

0.0

Sex (n, %)

 Male

3872

26.5

 Female

10,755

73.5

Geographic region (n, %)

 Northeast

2523

17.2

 North Central

4071

27.8

 South

5139

35.1

 West

2811

19.2

 Unknown

83

0.6

Index year (n, %)

 2007

2440

16.7

 2008

3129

21.4

 2009

1923

13.1

 2010

1729

11.8

 2011

1304

8.9

 2012

1248

8.5

 2013

976

6.7

 2014

919

6.3

 2015

750

5.1

 2016

209

1.4